网站地图 | 首页 | 资讯 | 循证 | 会讯 | 下载 | 图库 | 教学 | 动画 | 期刊 | 药品 | 文库 | 学会 | 留言 | 论坛 | 会议 | 
〒 您现在的位置: 中国动脉粥样硬化网 >> 资讯 >> 他山之石 >> 文章正文 热门图文
糖耐量异常新发现:心梗后长期预后重要的预测因子         ★★★ 【字体:
糖耐量异常新发现:心梗后长期预后重要的预测因子
作者:M. Bartn…    文章来源:European Heart Journal (2004) 25, 1990–1997    点击数:    更新时间:2007-7-20
    Aims Recent data revealed that patients with myocardial infarction (MI) have a high prevalence of previously unknown diabetes mellitus (DM) and impaired glucose tolerance (IGT). The added prognostic importance of this finding has not been prospectively explored. To investigate whether a newly detected abnormal glucose tolerance (IGT or DM) assessed early after an MI, is related to long-term prognosis.

    Methods and results Patients (n = 168; age 63.5 ± 9.3 years) with MI, no previous DM and admission blood glucose <11.0 mmol/l were followed for major cardiovascular events defined as the composite of cardiovascular death, non-fatal MI, non-fatal stroke or severe heart failure (HF). According to an oral glucose tolerance test (OGTT) before hospital discharge, 55 patients had normal and 113 abnormal glucose tolerance (GT). During the follow-up of median 34 months there were eight cardiovascular deaths, 15 patients had a recurrent MI, six had a stroke and ten severe HF. All patients who died from cardiovascular causes had abnormal GT. The composite cardiovascular event occurred in 31 (18%) patients. The robability of remaining free from cardiovascular events was significantly higher in patients with normal than abnormal GT (p = 0.002). Together with previous MI, abnormal GT was the strongest predictor of future cardiovascular events (hazard ratio 4.18; CI 1.26-13.84; p = 0.019).

    Conclusions Abnormal glucose tolerance is a strong risk factor for future cardiovascular events after myocardial infarction. Since it is common and possible to detect even during the hospital phase it may be a target for novel secondary preventive efforts.
  • 上一篇文章: 抑制糖基化和氧化应激对大鼠糖尿病肾病进程的影响

  • 下一篇文章: 降脂治疗膜性肾病
  • 发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
    热点文章
    · 第九届全国动脉硬化性疾病学术会
    · 糖耐量异常新发现:心梗后长期预
    · 第九次全国动脉硬化性疾病学术会
    · 普罗布考预防高密度脂蛋白受体SR
    · 高敏C反应蛋白增高的心血管高危患
    · 冠状动脉疾病患者长期普罗布考治
    · 糖耐量受损患者应用阿卡波糖治疗
    · 斑块内出血刺激颈动脉粥样硬化斑
    · 降胆固醇和抗氧化治疗对内皮依赖
    · 阿司匹林在冠心病患者中的合理应
    推荐文章
    · 第九届全国动脉硬化性疾病学术会
    · 第九次全国动脉硬化性疾病学术会
    · IAS中国行长春会议回顾
    · IAS中国行沈阳会议回顾
    · IAS中国行北京会议回顾
    · IAS中国行济南会议回顾
    · 预祝IAS中国行济南会议成功召开!
    · IAS中国行乌鲁木齐会议回顾
    · 预祝IAS中国行乌鲁木齐会议成功召
    · IAS中国行长沙会议回顾
    相关文章
  • 抗血小板治疗预防高危患者死

  • 【AHA2004】越过急诊室直接将

  • 【AHA2004】一级损伤法改善S

  • 30岁以上的吸烟者心梗发病率

  • FDA批准阿伐他汀可以用于心肌

  • 14%的心梗患者并未被发现是高

  • 【网友评论】(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)
    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 | 网站地图 |
    中国病生理学会动脉粥样硬化专业委员会 国际动脉粥样硬化学会中国分会(CAS) 协办
    Copyright © 2003 - 2005 中国动脉粥样硬化网(SINOAS.com) All Rights Reserved